Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence
In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (...
Saved in:
Published in | Viruses Vol. 13; no. 10; p. 1901 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
23.09.2021
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 1999-4915 1999-4915 |
DOI | 10.3390/v13101901 |
Cover
Abstract | In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (LRTI)) and Klebsiella pneumoniae (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy. By looking at bacterial strains and personalized phages used against them we tried to point towards possible adaptation strategies that are employed by these pathogens. Genome restriction-based Pulsed Field Gel Electrophoresis (PFGE) profiling of strains isolated before and after phage therapy hints towards two strategies of adaptation. In one patient case (Pseudomonas aeruginosa related lung infection) bacterial strains before and after phage therapy were indistinguishable according to their PFGE profiles, but differed in their phage susceptibility properties. On the other hand, in two other patient cases (Pseudomonas aeruginosa related LRTI and Klebsiella pneumoniae related UTI) bacterial adaptation strategy seemed to have resulted in diversification of infecting strains of the same species. With this work we want to attract more attention to phage resistance in general as well as to its role in phage therapy. |
---|---|
AbstractList | In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (LRTI)) and Klebsiella pneumoniae (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy. By looking at bacterial strains and personalized phages used against them we tried to point towards possible adaptation strategies that are employed by these pathogens. Genome restriction-based Pulsed Field Gel Electrophoresis (PFGE) profiling of strains isolated before and after phage therapy hints towards two strategies of adaptation. In one patient case (Pseudomonas aeruginosa related lung infection) bacterial strains before and after phage therapy were indistinguishable according to their PFGE profiles, but differed in their phage susceptibility properties. On the other hand, in two other patient cases (Pseudomonas aeruginosa related LRTI and Klebsiella pneumoniae related UTI) bacterial adaptation strategy seemed to have resulted in diversification of infecting strains of the same species. With this work we want to attract more attention to phage resistance in general as well as to its role in phage therapy. In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (LRTI)) and Klebsiella pneumoniae (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy. By looking at bacterial strains and personalized phages used against them we tried to point towards possible adaptation strategies that are employed by these pathogens. Genome restriction-based Pulsed Field Gel Electrophoresis (PFGE) profiling of strains isolated before and after phage therapy hints towards two strategies of adaptation. In one patient case (Pseudomonas aeruginosa related lung infection) bacterial strains before and after phage therapy were indistinguishable according to their PFGE profiles, but differed in their phage susceptibility properties. On the other hand, in two other patient cases (Pseudomonas aeruginosa related LRTI and Klebsiella pneumoniae related UTI) bacterial adaptation strategy seemed to have resulted in diversification of infecting strains of the same species. With this work we want to attract more attention to phage resistance in general as well as to its role in phage therapy.In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (LRTI)) and Klebsiella pneumoniae (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy. By looking at bacterial strains and personalized phages used against them we tried to point towards possible adaptation strategies that are employed by these pathogens. Genome restriction-based Pulsed Field Gel Electrophoresis (PFGE) profiling of strains isolated before and after phage therapy hints towards two strategies of adaptation. In one patient case (Pseudomonas aeruginosa related lung infection) bacterial strains before and after phage therapy were indistinguishable according to their PFGE profiles, but differed in their phage susceptibility properties. On the other hand, in two other patient cases (Pseudomonas aeruginosa related LRTI and Klebsiella pneumoniae related UTI) bacterial adaptation strategy seemed to have resulted in diversification of infecting strains of the same species. With this work we want to attract more attention to phage resistance in general as well as to its role in phage therapy. In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to (two patients, lower respiratory tract infection (LRTI)) and (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy. By looking at bacterial strains and personalized phages used against them we tried to point towards possible adaptation strategies that are employed by these pathogens. Genome restriction-based Pulsed Field Gel Electrophoresis (PFGE) profiling of strains isolated before and after phage therapy hints towards two strategies of adaptation. In one patient case ( related lung infection) bacterial strains before and after phage therapy were indistinguishable according to their PFGE profiles, but differed in their phage susceptibility properties. On the other hand, in two other patient cases ( related LRTI and related UTI) bacterial adaptation strategy seemed to have resulted in diversification of infecting strains of the same species. With this work we want to attract more attention to phage resistance in general as well as to its role in phage therapy. |
Author | Goderdzishvili, Marina Leshkasheli, Lika Dadiani, Mariam Nadareishvili, Lia Balarjishvili, Nana Askilashvili, Lia Kvatadze, Nino Zaldastanishvili, Elisabed Kutateladze, Mzia |
AuthorAffiliation | 1 Laboratory of Molecular Biology, Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia; l.leshkasheli@pha.ge (L.L.); laskilashvili@pha.ge (L.A.); n.balarjishvili@pha.ge (N.B.) 2 Eliava Phage Therapy Center (EPTC), 0160 Tbilisi, Georgia; mari.dadiani@gmail.com (M.D.); nadalia30.60@gmail.com (L.N.) 3 Laboratory of General Microbiology, Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia; nkvatadze27@gmail.com (N.K.); mgoderdzishvili@pha.ge (M.G.) 4 Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia; kutateladze@pha.ge |
AuthorAffiliation_xml | – name: 1 Laboratory of Molecular Biology, Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia; l.leshkasheli@pha.ge (L.L.); laskilashvili@pha.ge (L.A.); n.balarjishvili@pha.ge (N.B.) – name: 3 Laboratory of General Microbiology, Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia; nkvatadze27@gmail.com (N.K.); mgoderdzishvili@pha.ge (M.G.) – name: 2 Eliava Phage Therapy Center (EPTC), 0160 Tbilisi, Georgia; mari.dadiani@gmail.com (M.D.); nadalia30.60@gmail.com (L.N.) – name: 4 Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia; kutateladze@pha.ge |
Author_xml | – sequence: 1 givenname: Elisabed orcidid: 0000-0002-3326-178X surname: Zaldastanishvili fullname: Zaldastanishvili, Elisabed – sequence: 2 givenname: Lika surname: Leshkasheli fullname: Leshkasheli, Lika – sequence: 3 givenname: Mariam surname: Dadiani fullname: Dadiani, Mariam – sequence: 4 givenname: Lia orcidid: 0000-0002-6984-5090 surname: Nadareishvili fullname: Nadareishvili, Lia – sequence: 5 givenname: Lia surname: Askilashvili fullname: Askilashvili, Lia – sequence: 6 givenname: Nino surname: Kvatadze fullname: Kvatadze, Nino – sequence: 7 givenname: Marina surname: Goderdzishvili fullname: Goderdzishvili, Marina – sequence: 8 givenname: Mzia surname: Kutateladze fullname: Kutateladze, Mzia – sequence: 9 givenname: Nana surname: Balarjishvili fullname: Balarjishvili, Nana |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34696331$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktvEzEQgC3Uij7gwB9AlrjAIdReP9bmUAmiAJUqtYdytia748TRZh3sTUT_PQ4pUVNV6sn2-POnmfGckaM-9kjIO84-C2HZxYYLzrhl_BU55dbakbRcHT3an5CznBeMaW1Z_ZqcCKmtFoKfEridwwzp3RwTrO7p5M8KU8C-QQoDHeZIJ12ADdBDbIz9gOlLOSdEOoaMmUZPv0FTwgE6eosphzxsRW_IsYcu49uH9Zz8-j65G_8cXd_8uBp_vR41SpthpKH2WNVmqj36SrWAQjIwXDSV1FqLqWyRo659DbIBRAMSauQARlipOBPn5GrnbSMs3CqFJaR7FyG4f4GYZg7SEJoOHbRGoVdaeY9SgppqXhcDx9ZoVdW8uC53rtV6usS2KeUm6A6khzd9mLtZ3DijJGNMFcHHB0GKv9eYB7cMucGugx7jOrtKC62NNZV4GVVGS1VZIwv64Qm6iOvUl65uKakYZ6ou1PvHye-z_v_pBfi0A5oUc07o9whnbjtQbj9Qhb14wjZhgCHEbd2he-bFXyL3yvI |
CitedBy_id | crossref_primary_10_1089_phage_2023_0024 crossref_primary_10_3390_v14112339 crossref_primary_10_1016_j_cmi_2023_06_001 crossref_primary_10_1128_spectrum_03520_23 crossref_primary_10_1042_EBC20240012 crossref_primary_10_1016_j_coviro_2022_101290 crossref_primary_10_1089_phage_2022_0036 crossref_primary_10_1177_20499361241307841 crossref_primary_10_1097_CU9_0000000000000268 crossref_primary_10_1007_s41030_022_00210_y crossref_primary_10_1183_16000617_0029_2024 crossref_primary_10_3390_ijms25158321 crossref_primary_10_1016_j_coviro_2022_101209 crossref_primary_10_3390_antibiotics13020125 crossref_primary_10_3390_ijms242115628 crossref_primary_10_1089_phage_2023_0038 crossref_primary_10_3390_v15071484 crossref_primary_10_1128_cmr_00044_24 crossref_primary_10_1038_s41598_023_49880_x crossref_primary_10_1093_ofid_ofad221 crossref_primary_10_1038_s41598_025_91073_1 crossref_primary_10_1371_journal_pbio_3002119 crossref_primary_10_2174_0118742858281566231221045303 crossref_primary_10_1016_j_prrv_2023_08_001 crossref_primary_10_1080_19490976_2024_2387144 crossref_primary_10_1128_ecosalplus_esp_0029_2023 crossref_primary_10_1016_j_ijpharm_2023_123505 crossref_primary_10_1016_j_jhepr_2023_100909 crossref_primary_10_3390_ijms25052655 crossref_primary_10_1038_s41598_022_25352_6 crossref_primary_10_1016_j_prrv_2022_02_001 crossref_primary_10_3390_v17010115 crossref_primary_10_3390_v16121905 |
Cites_doi | 10.1093/jac/dky263 10.1177/1756287218814382 10.1016/S1473-3099(20)30330-3 10.1016/j.resmic.2018.05.001 10.1097/QCO.0000000000000127 10.1128/AAC.00954-17 10.1038/nrmicro2315 10.1093/cid/ciz782 10.1186/s13073-018-0525-6 10.1007/s10096-014-2100-4 10.1057/s41599-020-0478-4 10.1016/B978-0-12-394438-2.00001-3 10.1080/03009734.2019.1688433 10.1128/CMR.00066-18 10.1038/s41587-019-0133-z 10.3389/fmed.2017.00094 10.1097/01.ju.0000141497.46841.7a 10.1038/s41591-019-0437-z 10.3390/v11030265 10.1093/ofid/ofaa389 10.1007/978-1-60327-164-6_14 10.1128/CMR.00181-19 10.1080/14787210.2019.1694905 10.1093/cid/ciaa705 10.1038/s41591-020-0825-4 10.1016/S1473-3099(18)30482-1 10.3390/v10070351 |
ContentType | Journal Article |
Copyright | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
Copyright_xml | – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7U9 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM DOA |
DOI | 10.3390/v13101901 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AGRICOLA Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1999-4915 |
ExternalDocumentID | oai_doaj_org_article_ad85ef565ffe44a5b6171031ed865271 PMC8540005 34696331 10_3390_v13101901 |
Genre | Research Support, Non-U.S. Gov't Case Reports |
GeographicLocations | Georgia (Republic) |
GeographicLocations_xml | – name: Georgia (Republic) |
GroupedDBID | --- 2WC 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACUHS AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK E3Z EBD ESTFP ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M48 M7P MODMG M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RPM TR2 TUS UKHRP ALIPV CGR CUY CVF ECM EIF NPM 3V. 7U9 7XB 8FK AZQEC COVID DWQXO GNUQQ H94 K9. PKEHL PQEST PQUKI PRINS 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c568t-6a7fe278b6fef25dae340a813c246663b4de1e67f7a4caee8a4a7e1aa83945103 |
IEDL.DBID | M48 |
ISSN | 1999-4915 |
IngestDate | Wed Aug 27 01:31:27 EDT 2025 Tue Sep 30 16:42:46 EDT 2025 Fri Sep 05 11:03:31 EDT 2025 Sun Sep 28 10:31:10 EDT 2025 Sat Sep 20 15:12:19 EDT 2025 Thu Apr 03 06:52:32 EDT 2025 Wed Oct 01 03:28:36 EDT 2025 Thu Apr 24 22:55:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Pseudomonas aeruginosa Klebsiella pneumoniae phage therapy |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c568t-6a7fe278b6fef25dae340a813c246663b4de1e67f7a4caee8a4a7e1aa83945103 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ORCID | 0000-0002-3326-178X 0000-0002-6984-5090 |
OpenAccessLink | https://doaj.org/article/ad85ef565ffe44a5b6171031ed865271 |
PMID | 34696331 |
PQID | 2584501057 |
PQPubID | 2032319 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ad85ef565ffe44a5b6171031ed865271 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8540005 proquest_miscellaneous_2636689823 proquest_miscellaneous_2586452984 proquest_journals_2584501057 pubmed_primary_34696331 crossref_primary_10_3390_v13101901 crossref_citationtrail_10_3390_v13101901 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20210923 |
PublicationDateYYYYMMDD | 2021-09-23 |
PublicationDate_xml | – month: 9 year: 2021 text: 20210923 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Viruses |
PublicationTitleAlternate | Viruses |
PublicationYear | 2021 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Hoyle (ref_11) 2018; 169 Labrie (ref_17) 2010; 8 Cano (ref_7) 2020; 73 Petrosino (ref_28) 2018; 10 ref_14 ref_12 Lin (ref_21) 2014; 33 Ernst (ref_22) 2020; 26 Caflisch (ref_4) 2019; 17 Ferry (ref_10) 2018; 73 Barr (ref_1) 2019; 32 ref_18 Leitner (ref_5) 2021; 21 ref_15 Zhvania (ref_13) 2017; 4 Jault (ref_6) 2019; 19 Godaly (ref_23) 2015; 28 Nilsson (ref_27) 2019; 124 Corbellino (ref_8) 2020; 70 Dedrick (ref_9) 2019; 25 Clokie (ref_19) 2009; 501 Schmidt (ref_3) 2019; 37 Storme (ref_24) 2019; 11 ref_20 Aslam (ref_16) 2020; 7 Nickel (ref_25) 2005; 173 Chanishvili (ref_2) 2012; 83 Brives (ref_26) 2020; 6 |
References_xml | – volume: 73 start-page: 2901 year: 2018 ident: ref_10 article-title: Innovations for the Treatment of a Complex Bone and Joint Infection Due to Xdr Pseudomonas aeruginosa Including Local Application of a Selected Cocktail of Bacteriophages publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dky263 – volume: 11 start-page: 19 year: 2019 ident: ref_24 article-title: Risk Factors and Predisposing Conditions for Urinary Tract Infection publication-title: Ther. Adv. Urol. doi: 10.1177/1756287218814382 – volume: 21 start-page: 427 year: 2021 ident: ref_5 article-title: Intravesical Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate: A Randomised, Placebo-Controlled, Double-Blind Clinical Trial publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(20)30330-3 – volume: 169 start-page: 540 year: 2018 ident: ref_11 article-title: Phage Therapy against Achromobacter xylosoxidans Lung Infection in a Patient with Cystic Fibrosis: A Case Report publication-title: Res. Microbiol. doi: 10.1016/j.resmic.2018.05.001 – volume: 28 start-page: 88 year: 2015 ident: ref_23 article-title: Innate Immunity and Genetic Determinants of Urinary Tract Infection Susceptibility publication-title: Curr. Opin. Infect. Dis. doi: 10.1097/QCO.0000000000000127 – ident: ref_12 doi: 10.1128/AAC.00954-17 – volume: 8 start-page: 317 year: 2010 ident: ref_17 article-title: Bacteriophage Resistance Mechanisms publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro2315 – volume: 70 start-page: 1998 year: 2020 ident: ref_8 article-title: Eradication of a Multidrug-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Isolate Following Oral and Intra-Rectal Therapy with a Custom Made, Lytic Bacteriophage Preparation publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciz782 – volume: 10 start-page: 12 year: 2018 ident: ref_28 article-title: The Microbiome in Precision Medicine: The Way Forward publication-title: Genome Med. doi: 10.1186/s13073-018-0525-6 – volume: 33 start-page: 1533 year: 2014 ident: ref_21 article-title: Clinical and Microbiological Characteristics of Klebsiella pneumoniae from Community-Acquired Recurrent Urinary Tract Infections publication-title: Eur. J. Clin. Microbiol. Infect. Dis. doi: 10.1007/s10096-014-2100-4 – volume: 6 start-page: 100 year: 2020 ident: ref_26 article-title: Phage Therapy as a Potential Solution in the Fight against Amr: Obstacles and Possible Futures publication-title: Palgrave Commun. doi: 10.1057/s41599-020-0478-4 – volume: 83 start-page: 3 year: 2012 ident: ref_2 article-title: Phage therapy—history from Twort and D’herelle through Soviet experience to current approaches publication-title: Advances in Virus Research doi: 10.1016/B978-0-12-394438-2.00001-3 – volume: 124 start-page: 218 year: 2019 ident: ref_27 article-title: Pharmacological Limitations of Phage Therapy publication-title: Upsala J. Med. Sci. doi: 10.1080/03009734.2019.1688433 – volume: 32 start-page: e00066-18 year: 2019 ident: ref_1 article-title: Phage Therapy in the Postantibiotic Era publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00066-18 – volume: 37 start-page: 581 year: 2019 ident: ref_3 article-title: Phage Therapy’s Latest Makeover publication-title: Nat. Biotechnol. doi: 10.1038/s41587-019-0133-z – volume: 4 start-page: 94 year: 2017 ident: ref_13 article-title: Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome publication-title: Front. Med. doi: 10.3389/fmed.2017.00094 – volume: 173 start-page: 27 year: 2005 ident: ref_25 article-title: Management of Urinary Tract Infections: Historical Perspective and Current Strategies: Part 2--Modern Management publication-title: J. Urology doi: 10.1097/01.ju.0000141497.46841.7a – volume: 25 start-page: 730 year: 2019 ident: ref_9 article-title: Engineered Bacteriophages for Treatment of a Patient with a Disseminated Drug-Resistant Mycobacterium abscessus publication-title: Nat. Med. doi: 10.1038/s41591-019-0437-z – ident: ref_15 doi: 10.3390/v11030265 – volume: 7 start-page: ofaa389 year: 2020 ident: ref_16 article-title: Lessons Learned from the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States publication-title: Open Forum Infect. Dis. doi: 10.1093/ofid/ofaa389 – volume: 501 start-page: 141 year: 2009 ident: ref_19 article-title: Phage Host Range and Efficiency of Plating publication-title: Bacteriophages doi: 10.1007/978-1-60327-164-6_14 – ident: ref_14 doi: 10.1128/CMR.00181-19 – volume: 17 start-page: 1011 year: 2019 ident: ref_4 article-title: Biological Challenges of Phage Therapy and Proposed Solutions: A Literature Review publication-title: Expert Rev. Anti-Infect. Ther. doi: 10.1080/14787210.2019.1694905 – volume: 73 start-page: e144 year: 2020 ident: ref_7 article-title: Phage Therapy for Limb-Threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and in Vitro Characterization of Anti-Biofilm Activiy publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa705 – ident: ref_20 – volume: 26 start-page: 705 year: 2020 ident: ref_22 article-title: Adaptive Evolution of Virulence and Persistence in Carbapenem-Resistant Klebsiella pneumoniae publication-title: Nat. Med. doi: 10.1038/s41591-020-0825-4 – volume: 19 start-page: 35 year: 2019 ident: ref_6 article-title: Efficacy and Tolerability of a Cocktail of Bacteriophages to Treat Burn Wounds Infected by Pseudomonas aeruginosa (Phagoburn): A Randomised, Controlled, Double-Blind Phase 1/2 Trial publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(18)30482-1 – ident: ref_18 doi: 10.3390/v10070351 |
SSID | ssj0066907 |
Score | 2.4628909 |
Snippet | In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1901 |
SubjectTerms | Adult Aged Antibiotics Bacteria Bacteria - virology Bacterial Infections - therapy Bacteriophages Bronchopulmonary infection Case Report Clinical trials descriptive studies Drug resistance E coli Electrophoresis, Gel, Pulsed-Field Female Gel electrophoresis genome Genomes Georgia (Republic) Humans Infectious diseases Klebsiella Infections - therapy Klebsiella pneumoniae lungs Male Middle Aged Nosocomial infections Pathogens Patients Phage Therapy Phages Pseudomonas aeruginosa Pseudomonas aeruginosa - virology Pseudomonas Infections - therapy pulsed-field gel electrophoresis Respiratory tract diseases Respiratory Tract Infections - therapy Retrospective Studies Strains (organisms) Urinary tract urinary tract diseases Urinary Tract Infections - therapy Viral infections |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS91AEF-KUOhFqm1tqpat9NBL0Oxudvd5U1GkUOlBwVuY7M6iIHnl-RT633cmm5eaIu2lx2SHZD_m4zfZzW-E-JwwOPQplKGKtjRWhdKr0JbJ2oNICETPerqmbxf2_Mp8va6vn5T64jNhmR44T9w-RF9jItiREhoDdUshl0sTYPS2Vv3f44rC2CqZyj7Ycs6XeYQ0JfX7jxWhGA59k-jTk_Q_hyz_PCD5JOKcvRbrA1SUR7mLG-IFdpviZS4e-fONgO835AvkZaYFkL85iyUsJcE6eXp3C48gp2L8NRcXh3S9QJQnFMPu5TzJ40zaTK_jI_G89PSgt-Lq7PTy5LwcCiaUobZ-WVpwCZXzrU2YVB0BtTkAX-mgDKUpujURK7QuOTABED0YcFgBEEoyTK33Tqx18w7fCzmzns3TmDpaEziNchgTtgAxaQxQiC-riWzCwCbORS3uGsoqeM6bcc4LsTeK_sgUGs8JHfNqjALMet3fIF1oBl1o_qULhdhZrWUzmOJ9owhi1VwH1BXi09hMRsQ7I9Dh_KGX4Q3emTd_kbHaWj_zShdiK6vH2FttLDkyTR1wE8WZDGfa0t3e9GTeniAzecIP_2P82-KV4iM3vGmmd8TacvGAu4SZlu3H3jx-AX-sFW8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1BT90wDI4GaBIXtLEN3sambNphlwqapEneLtNAIDRp0w4gvVvlJg4goRbeeyDt389u-8o6IY5trDRNHPtzYn0W4nPC4NCnkIU82sxYFTKvQpUlaw8iIRA9bemafv6yp-fmx6yY9Qduiz6tcmUTW0Mdm8Bn5PuKPGXB5Rzdt5vbjKtG8e1qX0JjTWzkBFVYq91sCLgsR34dm5Cm0H7_Picsww5w5INaqv7H8OX_aZL_-J2TF2KrB4zye7fCL8UzrLfF866E5J9XAn5fkkWQZx05gHxgLpawlATu5PH1FdyDHIvxmS7Ov9LzHFEekSdbyCbJw466mT7HifGsANTRa3F-cnx2dJr1ZROyUFi_zCy4hMr5yiZMqoiA2hyAz3VQhoIVXZmIOVqXHJgAiB4MOMwBCCsZJth7I9brpsZdIafW8yY1pojWBA6mHMaEFUBMGgNMxJfVRJah5xTn0hbXJcUWPOflMOcT8WkQvemINB4TOuTVGASY-7p90cwvyn4rlRB9gYmAaEpoDBQVgTAuVoHR20I56mRvtZZlvyEX5YP6TMTHoZm2Et-PQI3NXSvD17xTb56QsdpaP_VKT8ROpx7DaLWxZM40DcCNFGf0O-OW-uqypfT2BJzJHr59eujvxKbilBq-FNN7Yn05v8P3hImW1YdW8f8CXosNJA priority: 102 providerName: ProQuest |
Title | Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34696331 https://www.proquest.com/docview/2584501057 https://www.proquest.com/docview/2586452984 https://www.proquest.com/docview/2636689823 https://pubmed.ncbi.nlm.nih.gov/PMC8540005 https://doaj.org/article/ad85ef565ffe44a5b6171031ed865271 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate - eBooks customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: ABDBF dateStart: 20091201 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: GX1 dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: RPM dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1999-4915 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1999-4915 dateEnd: 20250731 omitProxy: true ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: M48 dateStart: 20090401 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB_6gdIX8dvUeqzigy_RJtns7gkiXrlahJYiPbi3sNnM2sKRs-m12P_emXzVyOlLINlhk8zO7Pxmd_kNwFuPTqPxLnRRoUKpYhea2OWhV2q_IASSjGu6puMTdTST3-bpfAO6GputAq_WpnZcT2pWLd7_urz9TA7_iTNOStk_3ESEUTiwbcI2BaSYjftY9psJihPAhlRoKL4D9xPKDlVTYe4uKtXk_esQ598HJ_-IRIcP4UELIcWXZswfwQaWj-FeU1Ty9gnY03OaI8RZQxcg7riMhV0JgntiuriwN1YMxXiVF6uPdF8higOKbVdi6cWkIXOm1_FReTYJ6ugpzA6nZwdHYVtIIXSpMqtQWe0x1iZXHn2cFhYTuW9NlLhYUvqS5LLACJX22kpnEY2VVmNkLaEnyZR7z2CrXJb4AsRYGXZbKdNCScfplcbCY25t4RN0NoB3nSIz17KMc7GLRUbZBqs_69UfwJte9GdDrbFOaMKj0QswG3b9YFn9yFrnymxhUvQETb1HKW2aEyzj8hVYGJXGmjrZ68Yy6ywsiwl6pVwfVAfwum8m5-IdE1vi8rqW4Y3fsZH_kVGJUmZs4iSA54159F_bmVcAemA4g98ZtpQX5zXJtyEoTTPk7j_7fAk7MZ-v4R2yZA-2VtU1viKAtMpHsKnnegTbk-nJ6fdRvcxA16_zaFQ7xm_7JhLP |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4s2WAgaBxCXqxnZsBwkhWlpt6UMcttLeUscZ00pV0u5ui_qn-I3M5FUWVb31mGTkOOPxzDe28w1jHwJ4Azb4yMeFjpQWPrLC51HQelggApFpTde0t69HB-rHJJkssT_dvzB0rLLzibWjLipPa-RrAiNlQuUczdfTs4iqRtHualdCozGLHbj8jSnb7Mv2dxzfj0JsbY43RlFbVSDyibbzSDsTQBib6wBBJIUDqYbOxtILhVhe5qqAGLQJxinvAKxTzkDsHEIJRfxz2O4ddlfJoSKufjPpEzxNmWbDXiRlOly7iBE7UcBdiHl1aYDr8Oz_xzL_iXNbj9jDFqDyb41FPWZLUD5h95qSlZdPmft5hB6IjxsyAn7FlMzdnCOY5Jsnx-7C8UUxWkOG6We8ngLwDYycM14Fvt5QRePr6CA-GRw29Iwd3IpCn7PlsirhJeOptuQUlEoKrTwlbwaKALlzRZDg3YB96hSZ-ZbDnEppnGSYy5DOs17nA_a-Fz1tiDuuE1qn0egFiGu7vlFNf2Xt1M1cYRMICHxDAKVckiPoo-IYUFidCIONrHZjmbUOYJZdmeuAvesf49Sl_RhXQnVey9C2cmrVDTJaam1TK-SAvWjMo--tVBrdp8QOmAXDWficxSfl8VFNIW4RqKP_Xbm562_Z_dF4bzfb3d7fecUeCDrOQxtycpUtz6fn8Brx2Dx_U08Czg5ve9b9BfSESvA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4s2WAgaBxCXaje3YDhJC9LFqKVQ9tNLeUscZ00pV0u5ui_rX-HXMJNmUoKq3HjcZeR17Ht_Ek28Y-xDAG7DBRz4udKS08JEVPo-C1qMCEYhMa7qmn7t660B9nySTJfZn8S0MlVUufGLtqIvK0zvyocBImVA7RzMMbVnE3sb46-lZRB2k6KR10U6jUZEduPyN6dvsy_YG7vVHIcab--tbUdthIPKJtvNIOxNAGJvrAEEkhQOpRs7G0guFuF7mqoAYtAnGKe8ArFPOQOwcwgpFXHQ47h1210glqZzMTLpkT1PW2TAZSZmOhhcx4igKvr34V7cJuA7b_l-i-U_MGz9iD1uwyr812vWYLUH5hN1r2ldePmVu7wi9Ed9viAn4FWsyd3OOwJJvnhy7C8f7YvQ-Gaaf8fcUgK9jFJ3xKvC1hjYa_46K8kn5cKBn7OBWFvQ5Wy6rEl4ynmpLDkKppNDKUyJnoAiQO1cECd4N2KfFQma-5TOnthonGeY1tOZZt-YD9r4TPW1IPK4TWqPd6ASId7u-UE1_Za0ZZ66wCQQEwSGAUi7JEQBSowworE6EwUFWF3uZtc5gll2p7oC9626jGdPZjCuhOq9l6Ig5teoGGS21tqkVcsBeNOrRzVYqja5U4gRMT3F6j9O_Ux4f1XTiFkE7-uKVm6f-lt1He8t-bO_uvGIPBFX20NmcXGXL8-k5vEZoNs_f1DbA2eFtG91fPhVPKw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phage+Therapy+Experience+at+the+Eliava+Phage+Therapy+Center%3A+Three+Cases+of+Bacterial+Persistence&rft.jtitle=Viruses&rft.au=Zaldastanishvili%2C+Elisabed&rft.au=Leshkasheli%2C+Lika&rft.au=Dadiani%2C+Mariam&rft.au=Nadareishvili%2C+Lia&rft.date=2021-09-23&rft.eissn=1999-4915&rft.volume=13&rft.issue=10&rft_id=info:doi/10.3390%2Fv13101901&rft_id=info%3Apmid%2F34696331&rft.externalDocID=34696331 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon |